Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · Real-Time Price · USD

1.170

+0.020 (1.74%)

At close: Mar 5, 2026, 4:00 PM EST

1.190

+0.020 (1.71%)

Pre-market: Mar 6, 2026, 6:18 AM EST

Phio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Cost of Revenue	-	3.64	6.33	7.01	8.89	Upgrade
Gross Profit	-	-3.64	-6.33	-7.01	-8.89	Upgrade
Selling, General & Admin	4.6	3.74	4.37	4.45	4.63	Upgrade
Research & Development	4.62	-	-	-	-	Upgrade
Operating Expenses	9.22	3.74	4.37	4.45	4.63	Upgrade
Operating Income	-9.22	-7.39	-10.7	-11.46	-13.51	Upgrade
Interest Expense	-	-	-0.01	-	-	Upgrade
Interest & Investment Income	0.52	0.23	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0	0.01	0.01	-0.02	-0.01	Upgrade
EBT Excluding Unusual Items	-8.7	-7.15	-10.7	-11.48	-13.52	Upgrade
Asset Writedown	-	-	-0.13	-	-	Upgrade
Other Unusual Items	-	-	-	-	0.23	Upgrade
Pretax Income	-8.7	-7.15	-10.83	-11.48	-13.29	Upgrade
Net Income	-8.7	-7.15	-10.83	-11.48	-13.29	Upgrade
Net Income to Common	-8.7	-7.15	-10.83	-11.48	-13.29	Upgrade
Shares Outstanding (Basic)	6	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	6	1	0	0	0	Upgrade
Shares Change (YoY)	659.91%	240.15%	83.32%	6.30%	179.70%	Upgrade
EPS (Basic)	-1.45	-9.08	-46.76	-90.91	-111.84	Upgrade
EPS (Diluted)	-1.45	-9.08	-46.76	-90.91	-111.87	Upgrade
Free Cash Flow	-7.99	-7.11	-10.75	-12.25	-11.91	Upgrade
Free Cash Flow Per Share	-1.33	-9.03	-46.45	-97.00	-100.24	Upgrade
EBITDA	-9.22	-7.39	-10.64	-11.39	-13.44	Upgrade
D&A For EBITDA	0	0	0.06	0.07	0.08	Upgrade
EBIT	-9.22	-7.39	-10.7	-11.46	-13.51	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.